About the IBC

As defined by the NIH Guidelines, the NCI-Frederick Institutional Biosafety Committee (NCI-F IBC) was established to provide local review and oversight of nearly all forms of research utilizing recombinant DNA. The NCI-F IBC has also been charged to review research being conducted with pathogens, oncogenes, human materials, biological toxins, transgenic and/or knock-out/in animals and other potentially infectious material that is being performed at or sponsored by the NCI-F.

Current IBC Members

VOTING MEMBERS	AFFILIATION
Michael Baseler	Director, Applied/Development Research Support (SAIC)
Theresa Bell	NCI Biological Safety Officer; Environment, Health & Safety (SAIC)
David Betzner	Community Member – Reverend
Stephen Creekmore	Chief, Biological Resources Branch, DTP (NCI-F)
Bruce Crise	Director, Business Development, Advanced Technology Program (SAIC)
Eric Freed	Senior Investigator, Retroviral Replication Laboratory (NCI-F)
Melinda Hollingshead	Chief, Veterinary Medical Officer, Biological Testing Branch, DTP (NCI-F)
Sarah Hooper	Manager, Occupational Health Services (SAIC)
Stephen Hughes	Chief, Retroviral Replication Laboratory, HIV Drug Resistance Program (NCI-F)
Bhargavi Kondragunta	Cell Culture Scientist II (SAIC-F)
Serguei Kozlov	Senior Principal Scientist, Basic Research Program (NCI-F)
Dan McVicar (IBC Chairman)	Principal Investigator, Laboratory of Experimental Immunology (NCI-F)
Randall Morin	Director, Environment, Health & Safety (SAIC)
Raja Sriperumbudur	Manager R & Q, Animal Program Veterinarian (SAIC-F)
Lucien Winegar	Community Member – Attorney
EX OFFICIO MEMBERS	AFFILIATION
Walter Hubert	Assistant Project Officer/COTR, Office of Scientific Operations (NCI-F)
Kim DiGiandomenico	IBC Administrator (SAIC)